Sinovac says COVID-19 vaccine effective in preventing hospitalization, death

Feb 5 (Reuters) - China's Sinovac Biotech SVA.O on Friday said late-stage trial data of its COVID-19 vaccine from Brazil and Turkey showed the inoculation prevented hospitalization and death in COVID-19 patients, but had a much lower efficacy overall.

The 12,396-person trial found the CoronaVac vaccine was 100% effective for hospitalized, severe and fatal cases, 83.7% effective at stopping cases that require medical treatment and 50.65% for all cases, according to a statement.

(Reporting by Vishwadha Chander, editing by Peter Henderson and Sonya Hepinstall)

((Vishwadha.Chander@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132;))